Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal midazolam versus magnesium sulfate added to bupivacaine for postoperative pain after ureteric stone surgery
IRCT20260124068652N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of midazolam, magnesium sulfate and bupivacaine in postoperative pain (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Average blood pressure, Pulse rate and 4 more. Started Jun 2026; status: completed.
02
Drugs
midazolammagnesium sulfatebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20260124068652N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260124068652N1.